Skip to main content
Have a personal or library account? Click to login
Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs Cover

Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs

Slovenian Journal of Public Health
Volume 50 (2011): Issue 1 (March 2011)
By: ,  ,  ,   and    
Open Access
|Jan 2011
References

References

  1. Institute for safe medication practices: ISMP's list of high-alert medications. Pridobljeno 19.11.2009 s spletne strani:
    Search in Google Scholar
  2. Phillips J, Beam S, Brinker A, et al: Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-1841.
    Open DOISearch in Google Scholar
  3. Sonc M. Standardi kakovosti za področje onkološke farmacevtske dejavnosti. Ljubljana: Lekarniška zbornica Slovenije, 2009.
    Search in Google Scholar
  4. Department of Health: The NHS cancer plan. London, HMSO, No. 22293, 2001.
    Search in Google Scholar
  5. Green E, Johnston M, Trudeau M, Schwartz L, Poirer S, Macartney G, Milliken D. Safe handling of parenteral cytotoxics: recommenations for Ontario. J Oncol Pract posted online ahead of print on August 20, 2009.
    Open DOISearch in Google Scholar
  6. North East London Cancer Network NHS: Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London, Department of Health Publications, 2005.
    Search in Google Scholar
  7. American Society of Health System Pharmacists: ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006; 63: 1172-1193.
    Open DOISearch in Google Scholar
  8. Mort D, Lansdown M, Smith N, et al: For better, for worse? London, National Confidential Enquiry into Patient Outcome and Death, 2008.
    Search in Google Scholar
  9. Knez L, Laaksonen R, Duggan C, et al: Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-280.
    Search in Google Scholar
  10. Goldspiel BR, DeChristoforo R, Daniels CE: A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.
    Open DOISearch in Google Scholar
  11. Macintyre J, Dalrymple H, MacLean F, et al: Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-267.
    Search in Google Scholar
  12. Liekweg A, Westfeld M, Jaehde U: From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 3-79.
    Open DOISearch in Google Scholar
  13. Slama C, Jerome J, Jacquot C, et al: Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-343.
    Open DOISearch in Google Scholar
  14. Markert A, Thierry V, Kleber M, et al: Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-728.
    Open DOISearch in Google Scholar
  15. Bolnišnica Golnik KOPA. Pridobljeno 19.11.2009 s spletne strani:
    Search in Google Scholar
  16. Baza podatkov o zdravilih Republike Slovenije. Pridobljeno 4.12.2009 s spletne strani:
    Search in Google Scholar
  17. European Medicines Agency: Human Medicines. Pridobljeno 4.12.2009 s spletne strani:
    Search in Google Scholar
  18. Cancer Care Ontario: Cancer Drugs. Pridobljeno 4.12.2009 s spletne strani:
    Search in Google Scholar
  19. National Comprehensive Cancer Network: NCCN Chemotherapy Order Templates. Pridobljeno 4.12.2009 s spletne strani:
    Search in Google Scholar
  20. Kuhlmann MK, Burkhardt G, Köhler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-2480.
    Open DOISearch in Google Scholar
  21. Roila F, Hesketh PJ, Herrstedt J; Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer: Prevention of chemotherapy- and radiotherapy-indiced emesis: results of the 2004 Perugia Internetional Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.
    Open DOISearch in Google Scholar
  22. Floyd J, Mirza I, Sachs B, et al: Hepatotoxicity of chemotherapy. Semin Oncol 2006; 33: 50-67.
    Open DOISearch in Google Scholar
  23. Allan EL, Barker KN: Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-571.
    Open DOISearch in Google Scholar
  24. Pajk B: Neželeni učinki sistemskega zdravljenja raka. Onkologija za prakso, 2007; 2: 131-138.
    Search in Google Scholar
  25. Jaehde U, Liekwig A, Simos S, et al: Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-168.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10152-010-0024-7 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Journal RSS Feed
Language: English, Slovenian
Page range: 12 - 23
Published on: Jan 17, 2011
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Keywords:
clinical pharmacy,
drug therapy,
chemotherapy,
oncology,
cancer
Related subjects:
Medicine,
Clinical medicine,
Hygiene and environmental medicine

© 2011 Lea Knez, Maja Jošt, Janez Toni, Nadja Triller, Tanja Čufer, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons License.

Volume 50 (2011): Issue 1 (March 2011)
Previous article
Next article